Genomic Characterization of a RET Inhibitor-Resistant <i>RET</i> Fusion-Positive Lung Cancer by CSF Cell-Free DNA Hybrid Capture-Based Sequencing.

Choudhury, Noura J; Yang, Soo-Ryum; Arcila, Maria; Mohanty, Abhinita S; Boire, Adrienne; Drilon, Alexander

Genomic Characterization of a RET Inhibitor-Resistant RET Fusion-Positive Lung Cancer by CSF Cell-Free DNA Hybrid Capture-Based Sequencing.

Choudhury, Noura J; Yang, Soo-Ryum; Arcila, Maria; Mohanty, Abhinita S; Boire, Adrienne; Drilon, Alexander.

Afiliação

Choudhury NJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Yang SR; Department of Pathology, Diagnostic Molecular Pathology Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY.
Arcila M; Department of Pathology, Diagnostic Molecular Pathology Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY.
Mohanty AS; Department of Pathology, Diagnostic Molecular Pathology Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY.
Boire A; Department of Neurology, Human Oncology and Pathogenesis Program, Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY.
Drilon A; Weill Cornell Medical College, New York, NY.

JCO Precis Oncol ; 42020.

Article em En | MEDLINE | ID: mdl-33381675

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2020 Tipo de documento: Article